Beijing, China

Zhong Li

This inventor holds 4 USPTO granted patents and 9 published patent applications. Top assignees: Beijing Solobio Genetechnology Co., Ltd., Staidson (Beijing) Biopharmaceuticals Co., Ltd, Staidson (Beijing) Biopharmaceuticals Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhong Li. Retrieved from https://idiyas.com/inventor/zhong-li-oril8eqs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0

Average Co-Inventor Count = 2.3

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Zhong Li in Biopharmaceuticals

Introduction

Zhong Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibodies. His work focuses on innovative solutions that address critical health challenges.

Latest Patents

Zhong Li holds a patent for "Antibodies specifically recognizing PcrV and uses thereof." This patent includes antibodies, including antigen-binding fragments, that specifically recognize PcrV. Additionally, it provides methods for making and using these antibodies, showcasing his expertise in biopharmaceutical research.

Career Highlights

Zhong Li is associated with Staidson (Beijing) Biopharmaceuticals Co., Ltd., where he applies his knowledge and skills to advance the company's research initiatives. His work has been instrumental in developing new therapeutic options that can improve patient outcomes.

Collaborations

Zhong Li collaborates with notable colleagues, including Maorong Yu and Chao Wang. Their combined efforts contribute to the innovative research environment at Staidson, fostering advancements in biopharmaceuticals.

Conclusion

Zhong Li's contributions to the field of biopharmaceuticals through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for new therapeutic developments that can benefit society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…